Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Idioma
Intervalo de año de publicación
1.
Khirurgiia (Mosk) ; (8): 58-63, 2017.
Artículo en Ruso | MEDLINE | ID: mdl-28805780

RESUMEN

AIM: To compare an effectiveness of thoracic epidural anesthesia/analgesia, paravertebral and intercostal blockades in prevention of chronic post-thoracotomy pain syndrome (CPTPS) in oncosurgery. MATERIAL AND METHODS: There were 300 patients who underwent open surgery including lobectomy or pneumonectomy. Patients were randomized into 3 groups depending on type of anesthesia: TEA (n=100) - combined general and epidural anesthesia; PVB (n=50) - combined general and paravertebral anesthesia; ICB (n=50) - general anesthesia was supplemented by intercostal blockade after removal of the drug. RESULTS: CPTPS incidence was 34 and 40% in 6 months postoperatively after PVB and ICB, respectively (p>0.05). In TEA group this value was significantly lower compared with ICB group (23%, p<0.05). CONCLUSION: TEA contributes to significant reduction of CPTPS incidence, while paravertebral blockade does not affect the frequency of this complication.


Asunto(s)
Anestesia Epidural/métodos , Neoplasias Esofágicas/cirugía , Neoplasias Pulmonares/cirugía , Bloqueo Nervioso/métodos , Dolor Postoperatorio , Neumonectomía/efectos adversos , Toracotomía/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Manejo del Dolor/métodos , Dimensión del Dolor/métodos , Dolor Postoperatorio/diagnóstico , Dolor Postoperatorio/etiología , Dolor Postoperatorio/prevención & control , Neumonectomía/métodos , Toracotomía/métodos , Vinblastina/análogos & derivados
2.
Anesteziol Reanimatol ; (2): 41-4, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25055492

RESUMEN

PURPOSE OF THE STUDY: To assess the role of migraine history in the development of postoperative nausea and vomiting (PONV) in patients undergoing general and combined general-epidural anaesthesia. MATERIALS AND METHODS: 127 women with oncogynecological pathology were randomized into 3 groups according to anaesthesia method. Patients of the group C (comparative group; n = 43; 18 with migraine) received general anaesthesia. Patients of the Group CA (n = 40; 19 with migraine) received combined general-epidural anaesthesia. Patients of the group D (n = 44; 19 with migraine) received general anaesthesia with adding of Droperidolum. All patients received standard prophylactics of PONV- Ondansetronum 8 mg and dexamethasone 8 mg intravenous. RESULTS: In the group C a PONV occurred in 15 of 43 women (34.9%). PONV occurred in 6 of 18 women with migraine (33.3%) and in 9 of 25 women without migraine (36%). In the group CA a PONV occurred in 10 of 40 women (25%). PONV occurred in 8 of 19 women with migraine (42.1%) and in 2 of 21 women without migraine (9.5%; p = 0.036 in comparison with group C). In the group D a PONV occurred in 8 of 44 women (18.2%). PONV occurred in 1 of 19 women with migraine (5.3% p = 0.03 in comparison with group C and p = 0.008 with group CA) and in 7 of 25 women without migraine (28%; there was no significant difference with groups C and CA). CONCLUSIONS: Migraine history is a significant risk factor of PONV. Epidural component of anaesthesia does not effect on frequency of PONV in women with migraine, but Droperidolum use allows increasing the frequency of PONV.


Asunto(s)
Anestesia Epidural/métodos , Anestesia General/métodos , Trastornos Migrañosos/complicaciones , Náusea y Vómito Posoperatorios/etiología , Adulto , Anciano , Antieméticos/uso terapéutico , Dexametasona/uso terapéutico , Droperidol/uso terapéutico , Femenino , Neoplasias de los Genitales Femeninos/cirugía , Humanos , Persona de Mediana Edad , Ondansetrón/uso terapéutico , Náusea y Vómito Posoperatorios/epidemiología , Factores de Riesgo , Adulto Joven
3.
Anesteziol Reanimatol ; 59(4): 33-8, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25549484

RESUMEN

UNLABELLED: The article deals with a problem of prophylaxis of hepatic insufficiency in oncological patients after liver resections. MATERIALS AND METHODS: We analyzed data of effectiveness and safety of the use of Remaxol in oncological patients with hepatic metastasis of colorectal cancer--dynamics of indicators of cytolysis and cholestasis, hepatic protein synthesis, exchange of pigments, pro- and antioxidant system and the level of endogen intoxication in postoperative period. RESULTS: Use of Remaxol allows decreasing the duration of postoperative rehabilitation and intensive care unit staying.


Asunto(s)
Neoplasias Colorrectales/cirugía , Hepatectomía/efectos adversos , Insuficiencia Hepática/prevención & control , Neoplasias Hepáticas/cirugía , Succinatos/uso terapéutico , Neoplasias Colorrectales/patología , Femenino , Insuficiencia Hepática/etiología , Humanos , Pruebas de Función Hepática , Neoplasias Hepáticas/secundario , Masculino , Persona de Mediana Edad , Atención Perioperativa , Succinatos/administración & dosificación , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...